Balanced news tone
News Sentiment
XCUR sentiment intelligence
Exicure Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-4.0% over one week, -27.3% over four weeks, trend inactive, and below fair value.
XCUR stock trades on limited evidence as Exicure waits for filings
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
XCUR stock trades on limited evidence as Exicure waits for filings
Exicure Inc. (XCUR) stock is currently trading with limited market drivers, with the company's investor relations site being the primary source of information. The article emphasizes that without recent filings, fresh market data, or updated operational figures, any analysis must
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jul 2026 19:09
- Source
- Ad-hoc-news.de
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jul 2026 07:00
- Source
- TradingKey
Form 13D/A EXICURE For: 17 July By Investing.com
This article announces the filing of Form 13D/A for EXICURE, dated July 17. The brief report from Investing.com provides a headline update regarding this financial filing.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jul 2026 14:41
- Source
- Investing.com Nigeria
Form 4 Exicure Inc For: 17 July By Investing.com
This article provides notification of a Form 4 filing for Exicure Inc. from July 17. Form 4 filings are used to report changes in beneficial ownership of a company's securities by insiders. The article also lists the current stock performance of XCUR for the day mentioned.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 21:44
- Source
- Investing.com Nigeria
Exicure, Inc. (XCUR) holder Exicure HiTron regains 623,275 returned shares
Exicure HiTron Inc., a major shareholder of EXICURE, INC. (XCUR), has reported the acquisition of 623,275 common shares through a series of "code J" transactions between June 23 and July 8, 2026, each priced at $4.50. These shares were returned to Exicure HiTron due to share tran
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 17 Jul 2026 20:39
- Source
- Stock Titan
Exicure HiTron boosts Exicure (XCUR) holding to 2.22M shares, 34.87%
Exicure HiTron Inc. has increased its beneficial ownership in Exicure, Inc. (XCUR) to 34.87%, holding 2,222,224 shares after amending previous share transfer transactions. This change resulted from five purchasers returning an aggregate of 623,277 Exicure shares to Exicure HiTron
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 16:39
- Source
- Stock Titan
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jul 2026 07:00
- Source
- Market source
Trending Stocks Today | Exicure Shoots up 31.39% Post-Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 21:41
- Source
- Moomoo
12 Health Care Stocks Moving In Tuesday's After-Market Session
This article lists 12 healthcare stocks that experienced significant movement during Tuesday's after-market trading session. It details both gainers like Exicure (XCUR) and Catheter Precision (VTAK), which saw increases of 38.4% and 21.23% respectively, and losers such as Basel M
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 20:40
- Source
- Benzinga
Exicure Inc. (XCUR) Q2 2022 Earnings: Significant Earnings Miss and Negative Stock Reaction - Earnings Sentiment Score
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 13 Jul 2026 17:44
- Source
- dars.gov.et
How Exicure Inc. (XCUR) Affects Rotational Strategy Timing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 16:18
- Source
- Stock Traders Daily
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 07:00
- Source
- Market source
Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under Scrutiny - Dark Pool Prints
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- dars.gov.et
Exicure Inc. (XCUR) Slips 7.89%: Key Support Levels Under Scrutiny - Volatility Skew
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- dars.gov.et
Exicure stock holds its line. Company context stays front and center.
Exicure (XCUR) stock remains tied to its corporate profile and Nasdaq listing context, as investors focus on the company's background, filings, and operating setup due to the absence of a clear, immediate catalyst. The company's business history in biotech research and developmen
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 15:40
- Source
- AD HOC NEWS
Debt to assets ratio of Exicure, Inc. – DUS:2H0
The article focuses on the debt to assets ratio of Exicure, Inc. (DUS:2H0), a biotechnology company listed on the Dusseldorf Stock Exchange. It provides context for accessing this financial metric within the TradingView platform, emphasizing its availability under the "Financials
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 07 Jul 2026 12:11
- Source
- TradingView
Non-controlling/minority interest of Exicure, Inc. – DUS:2H0
This article provides financial information for Exicure, Inc., specifically focusing on its non-controlling/minority interest under the ticker DUS:2H0 on the Dusseldorf Stock Exchange. It indicates that the market was closed with no trades at the time of publication. The content
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 11:40
- Source
- TradingView
Enterprise value to EBITDA forward of Exicure, Inc. – NASDAQ:XCUR
This article provides financial information for Exicure, Inc. (NASDAQ: XCUR), specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's stock information, market status, and references financial data providers like ICE Data Servi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 10:39
- Source
- TradingView
Exicure stock leans on its cash position. Nasdaq listing keeps it visible.
Exicure Inc. (XCUR) is a Nasdaq-listed biotechnology company whose stock performance is currently driven by its cash position, Nasdaq listing visibility, and future corporate updates rather than immediate product news. The company focuses on early-stage nucleic-acid-based therapi
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 03 Jul 2026 17:41
- Source
- Ad-hoc-news.de
Exicure announces board changes, adds two new directors By Investing.com
Exicure (NASDAQ:XCUR) announced changes to its board of directors, including the resignation of Jung Kyu Ham and the appointment of Jin Young Go and Eui Seok Han as new Class III directors. These changes come as the biotechnology company's stock has declined significantly and it
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 01 Jul 2026 09:09
- Source
- Investing.com Nigeria
Exicure Announces Board and Committee Changes
Exicure, Inc. has announced several changes to its Board of Directors and Board committees. Jung Kyu Ham resigned as a director, and Jin Young Go was appointed as a Class III director. The Board also increased its size from five to six directors, appointing Eui Seok Han as a Clas
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 20:39
- Source
- The Manila Times
New directors join Exicure (NASDAQ: XCUR) board as compensation committee forms
Exicure (NASDAQ: XCUR) is restructuring its board, with director Ham Jung Kyu resigning and two new Class III directors, Han Eui Seok and Go Jin Young, joining effective June 30, 2026, increasing the board size from five to six. Concurrently, the company established a new Compens
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 18:56
- Source
- Stock Titan
Exicure announces board changes, adds two new directors
Exicure, Inc. (NASDAQ:XCUR) announced changes to its board of directors, including the resignation of Jung Kyu Ham and the appointment of Jin Young Go and Eui Seok Han as new Class III directors. These changes expand the board to six members, maintaining Nasdaq's independence req
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 12:40
- Source
- Investing.com
Exicure expands board to 6, names 2 new directors
Exicure (Nasdaq:XCUR) announced changes to its Board of Directors and Board committees, expanding its board from five to six members. Jin Young Go and Eui Seok Han were appointed Class III directors, with Han qualifying as an independent director under Nasdaq Listing Rules. The c
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 30 Jun 2026 12:39
- Source
- Stock Titan
Exicure refreshes board with new independent directors
Exicure (XCUR) announced a refresh of its board of directors, with Ham Jung Kyu resigning and Go Jin Young and Han Eui Seok appointed as new Class III directors. The company expanded its board from five to six members and formed a new Compensation Committee. These changes are aim
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 12:11
- Source
- The Globe and Mail
Price to book forward of Exicure, Inc. – NASDAQ:XCUR
This article provides the "Price to book forward" financial metric for Exicure, Inc. (NASDAQ: XCUR). The content is primarily a data point within a larger financial platform, indicating the value and change of this specific financial ratio for the company.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 04:40
- Source
- TradingView
Price to earnings forward of Exicure, Inc. – NASDAQ:XCUR
This article displays the "Price to earnings forward" metric for Exicure, Inc. (NASDAQ: XCUR). The page is primarily a data placeholder from TradingView, indicating that specific financial data for this metric exists and can be viewed for various periods, though no actual values
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jun 2026 14:08
- Source
- TradingView
Exicure, Inc. Actuals & Estimates (NASDAQ:XCUR)
This article provides an overview of Exicure, Inc. (NASDAQ:XCUR) stock, including its current price, market capitalization, and historical performance. It also details financial estimates, upcoming earnings dates, and key financial metrics like net income. The company currently h
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 26 Jun 2026 09:39
- Source
- TradingView
Exicure Inc (XCUR) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Exicure Inc (XCUR), noting its current valuation score is 8.72, ranking 99th out of 388 in its industry. It highlights the company's P/E ratio of -3.42, which is significantly below its recent high and above its recent low. However, i
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 17:10
- Source
- TradingKey
Enterprise value of Exicure, Inc. – DUS:2H0
This article focuses on the enterprise value of Exicure, Inc. (DUS:2H0) as presented on TradingView. It indicates that the market for this financial instrument is currently closed with no trades. The page provides an overview of financials, news, and community related to Exicure,
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 16:10
- Source
- TradingView